Literature DB >> 16762425

Neurotransmitter transporters: molecular function of important drug targets.

Ulrik Gether1, Peter H Andersen, Orla M Larsson, Arne Schousboe.   

Abstract

The concentration of neurotransmitters in the extracellular space is tightly controlled by distinct classes of membrane transport proteins. This review focuses on the molecular function of two major classes of neurotransmitter transporter that are present in the cell membrane of neurons and/or glial cells: the solute carrier (SLC)1 transporter family, which includes the transporters that mediate the Na(+)-dependent uptake of glutamate, and the SLC6 transporter family, which includes the transporters that mediate the Na(+)-dependent uptake of dopamine, 5-HT, norepinephrine, glycine and GABA. Recent research has provided substantial insight into the structure and function of these transporters. In particular, the recent crystallizations of bacterial homologs are of the utmost importance, enabling the first reliable structural models of the mammalian neurotransmitter transporters to be generated. These models should be an important tool for developing specific drugs that, through selective interaction with transporters, could improve the treatment of serious neurological and psychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16762425     DOI: 10.1016/j.tips.2006.05.003

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  116 in total

1.  Arousal from sleep in response to intermittent hypoxia in rat pups is modulated by medullary raphe GABAergic mechanisms.

Authors:  Robert A Darnall; Robert W Schneider; Christine M Tobia; Benjamin M Zemel
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-12-07       Impact factor: 3.619

Review 2.  The solute carrier 6 family of transporters.

Authors:  Stefan Bröer; Ulrik Gether
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

3.  Functional and electrophysiological characterization of four non-truncating mutations responsible for creatine transporter (SLC6A8) deficiency syndrome.

Authors:  Vassili Valayannopoulos; Naziha Bakouh; Michel Mazzuca; Luc Nonnenmacher; Laurence Hubert; Fatna-Léa Makaci; Allel Chabli; Gajja S Salomons; Caroline Mellot-Draznieks; Emilie Brulé; Pascale de Lonlay; Hervé Toulhoat; Arnold Munnich; Gabrielle Planelles; Yves de Keyzer
Journal:  J Inherit Metab Dis       Date:  2012-05-30       Impact factor: 4.982

4.  Substrate-induced unlocking of the inner gate determines the catalytic efficiency of a neurotransmitter:sodium symporter.

Authors:  Christian B Billesbølle; Mie B Krüger; Lei Shi; Matthias Quick; Zheng Li; Sebastian Stolzenberg; Julie Kniazeff; Kamil Gotfryd; Jonas S Mortensen; Jonathan A Javitch; Harel Weinstein; Claus J Loland; Ulrik Gether
Journal:  J Biol Chem       Date:  2015-09-11       Impact factor: 5.157

5.  Studies of the biogenic amine transporters. 14. Identification of low-efficacy "partial" substrates for the biogenic amine transporters.

Authors:  Richard B Rothman; John S Partilla; Michael H Baumann; Catrissa Lightfoot-Siordia; Bruce E Blough
Journal:  J Pharmacol Exp Ther       Date:  2012-01-23       Impact factor: 4.030

6.  Trimerization of dopamine transporter triggered by AIM-100 binding: Molecular mechanism and effect of mutations.

Authors:  Mary Hongying Cheng; Luca Ponzoni; Tatiana Sorkina; Ji Young Lee; She Zhang; Alexander Sorkin; Ivet Bahar
Journal:  Neuropharmacology       Date:  2019-06-20       Impact factor: 5.250

7.  γ-Aminobutyric acid (GABA) signalling in human pancreatic islets is altered in type 2 diabetes.

Authors:  J Taneera; Z Jin; Y Jin; S J Muhammed; E Zhang; S Lang; A Salehi; O Korsgren; E Renström; L Groop; B Birnir
Journal:  Diabetologia       Date:  2012-04-27       Impact factor: 10.122

8.  Quinine enhances the behavioral stimulant effect of cocaine in mice.

Authors:  Adriana Huertas; William D Wessinger; Yuri V Kucheryavykh; Priscila Sanabria; Misty J Eaton; Serguei N Skatchkov; Legier V Rojas; Gerónimo Maldonado-Martínez; Mikhail Y Inyushin
Journal:  Pharmacol Biochem Behav       Date:  2014-12-05       Impact factor: 3.533

Review 9.  Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease.

Authors:  Kelly M Lohr; Shababa T Masoud; Ali Salahpour; Gary W Miller
Journal:  Eur J Neurosci       Date:  2016-09-02       Impact factor: 3.386

10.  The binding sites for cocaine and dopamine in the dopamine transporter overlap.

Authors:  Thijs Beuming; Julie Kniazeff; Marianne L Bergmann; Lei Shi; Luis Gracia; Klaudia Raniszewska; Amy Hauck Newman; Jonathan A Javitch; Harel Weinstein; Ulrik Gether; Claus J Loland
Journal:  Nat Neurosci       Date:  2008-06-22       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.